A LinkedIn post from Bright Uro highlights that Urology Specialists Clinic and Ambulatory Surgical Center in South Dakota has adopted the Glean Urodynamics System. The post notes that the clinic, led by Dr. Lauren Wood Thum, is described as the first in the state to implement this technology.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, Dr. Wood Thum characterizes Glean as transforming the clinic’s approach to urodynamics by enabling diagnoses in any exam room, which is portrayed as improving patient comfort and staff efficiency. This early clinical adoption may indicate growing provider interest in Bright Uro’s platform and could support future commercialization and revenue traction if similar deployments scale.
The post further positions the clinic’s use of Glean as aligning innovation with patient-centered care, suggesting Bright Uro is targeting practices that market themselves on advanced technology and workflow efficiency. For investors, broader uptake in ambulatory surgical centers and specialty clinics could expand the addressable market in urodynamics and strengthen Bright Uro’s competitive position in urology diagnostics.
While the post does not disclose financial terms, volumes, or pricing, the reference to being the first adopter in South Dakota points to an early geographic expansion narrative. Continued announcements of new clinical sites and positive user feedback would be key indicators for assessing product-market fit, potential recurring revenue from installed systems, and the durability of Bright Uro’s growth trajectory in this niche segment.

